Wave Life Sciences (WVE) Other Non-Current Liabilities (2014 - 2023)
Wave Life Sciences (WVE) posted Other Non-Current Liabilities of $190000.0 for Q2 2023, little changed on a QoQ basis from $190000.0 in Q1 2023.
Wave Life Sciences (WVE) Other Non-Current Liabilities (2014 - 2023) Analysis & Trends
Wave Life Sciences' Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $190000.0 for Q2 2023.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $190000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $190000.0 (changed N/A YoY) and the FY2022 annual result came in at $190000.0, changed N/A from the prior year.
- Other Non-Current Liabilities was $190000.0 for Q2 2023 at Wave Life Sciences, roughly flat from $190000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.0 million in Q1 2019 and bottomed at $190000.0 in Q4 2022.
- A 5-year average of $1.0 million and a median of $1.0 million in 2021 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 113.27% — and 2023, when it plunged 78.11%.
- Wave Life Sciences' Other Non-Current Liabilities stood at $1.7 million in 2019, then tumbled by 72.46% to $474000.0 in 2020, then jumped by 113.92% to $1.0 million in 2021, then plunged by 81.26% to $190000.0 in 2022, then changed by 0.0% to $190000.0 in 2023.
- Business Quant data shows WVE's Other Non-Current Liabilities at $190000.0 in Q2 2023, $190000.0 in Q1 2023, and $190000.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 190,000.00 |
| Mar 31, 2023 | 190,000.00 |
| Dec 31, 2022 | 190,000.00 |
| Mar 31, 2022 | 868,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 339,000.00 |
| Mar 31, 2021 | 407,000.00 |
| Dec 31, 2020 | 474,000.00 |
| Sep 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 1.52 Mn |
| Mar 31, 2020 | 1.62 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Sep 30, 2019 | 1.79 Mn |
| Jun 30, 2019 | 1.90 Mn |
| Mar 31, 2019 | 2.04 Mn |
| Dec 31, 2018 | 2.14 Mn |
| Sep 30, 2018 | 1.50 Mn |
| Jun 30, 2018 | 1.53 Mn |
| Mar 31, 2018 | 1.61 Mn |
| Dec 31, 2017 | 1.62 Mn |